Navigation Links
Takeda Completes Acquisition of Millennium
Date:5/14/2008

OSAKA, Japan, and CAMBRIDGE, Mass., May 14 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Millennium Pharmaceuticals, Inc. ("Millennium", Nasdaq: MLNM) today announced the completion of Takeda's acquisition of Millennium for US$25.00 per share in cash. Takeda completed the acquisition through a tender offer and subsequent merger of a wholly-owned subsidiary of Takeda into Millennium. Millennium is now a wholly-owned subsidiary of Takeda.

"The successful completion of this transaction underscores our ongoing commitment to becoming a global leader in oncology by delivering novel therapies that improve the standards of care for patients. Additionally, the Millennium clinical trial programs for irritable bowel disease (IBD) will enhance our GI franchise. We look forward to a successful transition by working closely with the talented Millennium employees now that they are part of Takeda," said Yasuchika Hasegawa, President of Takeda Pharmaceutical Company Limited.

"As part of the Takeda Group, Millennium will continue its commitment to developing breakthrough medicines that will benefit patients around the world. Millennium is excited to serve as Takeda's global center for oncology as we work with our new colleagues at Takeda to drive scientific excellence and create a world-class pipeline and products," said Deborah Dunsire, M.D., President and Chief Executive Officer of Millennium.

As a result of the merger, each outstanding share of Millennium common stock not validly tendered and accepted for payment in the tender offer (other than any shares in respect of which appraisal rights are validly exercised under Delaware law and any shares owned by Millennium, Takeda or any of their subsidiaries) was converted into the right to receive the same US$25.00 cash per share price paid in the tender offer. Effective after the close of market today, trading in Millennium common stock on the Nasdaq Global Select Market wi
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
2. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
3. Takeda Announces New U.S. Leadership
4. Takeda submits new drug application for alogliptin (syr-322) in the US
5. Chemizon Announces Research Collaboration Expansion With Takeda
6. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
7. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
8. InfoLogix Completes $25 Million Senior Debt Financing
9. ConforMIS Completes Executive Team With Addition of CFO
10. Facet Solutions, Inc. Completes Combination Facet Joint and Disc Replacement Study
11. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... Traditional healthcare,s uncertai... affordable alternative care. Affordable Acupunctu... (PRWEB) November 29, 2009 -- Affordable A...is year (2009) and has been met with enthusiasm an...uccess can be attributed to two things, need and c...
(Date:11/28/2009)..., CHICAGO, Nov. 28 Get ready f...ice in the clinical routine when Siemens intro...Assembly and Annual Meeting of the Radiological So...December 3 at McCormick Place (Booth #825, East Bu... syngo. via , Siemens, new imaging software ...
(Date:11/28/2009)...ds gene variation believed to affect circadian rhy... News) -- New research suggests that an internal b... in the development of bipolar disorder in childre...of the genetic makeup of 152 children with bipolar...jor mood swings, and 140 children without the diso...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall/...ny"), a supplier of precision technology products ... annual meeting of the Company,s shareholders has ...me and location of the meeting will be announced i...y received a requisition notice from Stephen Bersh...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today...1 virus genomic data. It shows that the lethality...d. 4.5) during the virus,s current outbreak in the...s week of 2.0 (s.d. 0.1). The H1N1 infectivity cou... Boston (PRWEB) November 27, 2009 -- Biote...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...neurological symptoms have higher chance of proble...(HealthDay News) -- Newborns who were not breathin...eased risk of having a low IQ, even if they showed...ebral palsy is a period of lack of oxygen, newborn...
...l 20 Boston Scientific Corporation (NYSE: BSX )...uarter ended March 31, 2009, as well as guidance f...second quarter and full year of 2009. , , , Fi...h in line with guidance (GAAP loss per share of $0...
... 20 The managing director of Publication CONNEXIO...d to speak at the 45th Annual Drug Information Ass.... Singer will be present a talk entitled "Effectiv...s from all facets within the industry. , , Follo...
... the only reason lizards and other cold-blooded cr...shed in the May/June issue of Physiological and B...hing behavior based on their need for vitamin D. ,... University who led the study. "Our results sugges...
... Young Innovations, Inc. (Nasdaq: YDNT ) today ... earnings results with a live and on-demand web ca...1:00 a.m. Central Time. A live audio broadcast of...ugh the Company,s website, www.ydnt.com . , , ...
...il 20 Insulet Corporation (Nasdaq: PODD ), the ... its OmniPod(R) Insulin Management System, announc...first quarter 2009 on Thursday, May 7, 2009 after ...rst quarter 2009 financial results. During the con...
Other Medicine News:Health News:Resuscitated Newborns at Risk for Lower IQs 2Health News:Resuscitated Newborns at Risk for Lower IQs 3Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 2Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 3Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 4Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 5Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 6Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 7Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 8Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 9Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 10Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 11Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 12Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 13Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 14Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 15Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 16Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 17Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 18Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 19Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 20Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 21Health News:Study: Lizards bask for more than warmth 2Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2Health News:Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009 2
(Date:11/27/2009)...7 At the upcoming Radiological Soc...ng Sunday, Royal Philips Electronics ( PHG, AEX: P...ging and informatics solutions designed to directl...iders, by delivering meaningful imaging innovation...oints and easy upgradability. This focus will ena...
(Date:11/25/2009)... Nov. 25 Heska Corporati...anced diagnostic and specialty products to the vet...Roche Diagnostics Corporation for the supply of bl...e veterinary market. ,, (Logo: http://www...., "Heska and Roche share the same passion for inno...
(Date:11/25/2009)...Switzerland, Nov. 25 From Novembe...ative hearing solutions, presented the second edit...using on the special needs of the older population...in aging and audiology from around the world and m...er people with hearing loss for an opportunity to ...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3The Donor Source International LLC Opens Office in New England 55076 1Dominique Wilkins Scores Big for Diabetes in Fayette County 55073 1Dominique Wilkins Scores Big for Diabetes in Fayette County 55073 2Dominique Wilkins Scores Big for Diabetes in Fayette County 55073 3Dopamine Lets Bad Experiences Linger 55071 1Dopamine Lets Bad Experiences Linger 55071 2Dopamine Lets Bad Experiences Linger 55071 3
...l, a leading,global provider of information resour...day announced the addition of a robust new drug,ef...pharmacy education,resource, AccessPharmacy (http...ith,Doctor Evidence, developer of distributed data...acy now provides in-context access to drug efficac...
...n and is Well Tolerated in Hunt...Further Development in Huntington,s Disease - ....m. EDT -, SAN FRANCISCO, July 7 Medivation, Inc...s of a Phase 2 study showing,that its investigatio...ive,function in patients with mild-to-moderate Hun...
Other Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5
Freedom Clear® LS External Catheters
Natural Male External Catheters
...Medical® clear, all-silicone Foley catheters e...oley catheter designs. As an inert, toxin-free ela...endable Foley catheter. Unlike silicone-coated lat...ers will not leach chemicals or water-soluble prot...
...lled-release nitrofurazone Foley catheter, RELEASE...eter is the first and only Foley that works as a d... RELEASE-NF catheter delivers the drug nitrofurazo... of the urethral tract. Unlike coated catheters, w...
Medicine Products: